To compare the efficacy and safety of pegylated G-CSF versus non-pegylated G-CSF for patients after HSCT.
This is a protocol.
Pegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for patients after hematopoietic stem cell transplantation
You may also be interested in:
- Prevention of occlusion of small veins in the liver after blood-forming stem cell transplantation
- Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation
- Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation
- Anti-thymocyte globulins for the prevention of graft-versus-host disease in patients receiving allogeneic stem cell transplantation
- High-dose chemotherapy plus single vs tandem autologous transplantation as initial treatment for multiple myeloma